Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011]
ABCC9 (ATP Binding Cassette Subfamily C Member 9) is a Protein Coding gene. Diseases associated with ABCC9 include Cantu Syndrome and Cardiomyopathy, Dilated, 1O. Among its related pathways are Regulation of activated PAK-2p34 by proteasome mediated degradation and Cardiac conduction. Gene Ontology (GO) annotations related to this gene include transporter activity and ion channel binding. An important paralog of this gene is ABCC8.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH12J021939 | Promoter/Enhancer | 1.7 | EPDnew Ensembl ENCODE CraniofacialAtlas | 600.7 | +1.7 | 1714 | 3.6 | CTCF ATF7 TEAD4 REST KDM1A SP1 EZH2 CEBPB USF1 ATF3 | ABCC9 lnc-CMAS-3 piR-47211-122 KCNJ8 | |
GH12J021971 | Enhancer | 0.6 | Ensembl ENCODE | 12.4 | -29.1 | -29050 | 1.2 | FOS TBP DACH1 | ABCC9 piR-55194-087 piR-32023-054 CMAS | |
GH12J021831 | Enhancer | 0.7 | Ensembl ENCODE | 5.6 | +110.5 | 110498 | 1.7 | SP1 ATF3 YY1 JUND NR2F2 RAD21 EGR1 RXRA SMARCA4 | ABCC9 ENSG00000257022 ENSG00000275567 KCNJ8 piR-57176-116 | |
GH12J022378 | Enhancer | 0.7 | FANTOM5 Ensembl | 1.3 | -436.1 | -436072 | 2.4 | FOSL1 TCF12 IKZF1 SMARCE1 TEAD4 CBFA2T2 CBFA2T3 ARID1B | C2CD5 ABCC9 ENSG00000256714 piR-48326-002 ST8SIA1 lnc-ST8SIA1-3 CMAS | |
GH12J021891 | Enhancer | 1.1 | VISTA Ensembl ENCODE | 0.2 | +50.6 | 50627 | 1.5 | SP1 FOXA2 ATF3 YY1 ZBTB33 JUND RAD21 HNF4A RXRA MAX | piR-57176-116 ABCC9 ENSG00000275567 KCNJ8 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000166 | nucleotide binding | IEA | -- |
GO:0005261 | contributes_to cation channel activity | ISS | 26621776 |
GO:0005267 | contributes_to potassium channel activity | IMP | 24439875 |
GO:0005524 | ATP binding | IEA | -- |
GO:0008281 | sulfonylurea receptor activity | IEA,ISS | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | TAS | -- |
GO:0008282 | inward rectifying potassium channel | ISS | -- |
GO:0016020 | membrane | IEA,IBA | 21873635 |
GO:0016021 | integral component of membrane | IEA | -- |
GO:0030017 | sarcomere | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Cardiac conduction |
.39
|
|
2 | Regulation of activated PAK-2p34 by proteasome mediated degradation |
.31
|
|
3 | Inwardly rectifying K+ channels | ||
4 | Antiarrhythmic Pathway, Pharmacodynamics | ||
5 | Transmission across Chemical Synapses |
.62
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006813 | potassium ion transport | IEA | -- |
GO:0033198 | response to ATP | ISS | 26621776 |
GO:0051607 | defense response to virus | IMP | 18026101 |
GO:0055085 | transmembrane transport | IBA,TAS | -- |
GO:0061337 | cardiac conduction | IMP | 24439875 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Glyburide | Approved | Pharma | Channel blocker, Inhibitor, Inhibition, Target, modulator | Kir6 (KATP) channel blocker | 127 | |
Nicorandil | Approved, Investigational | Pharma | Activator, Target, activator | Potassium channel activator, Kir6 (KATP) channel opener and NO donor | 23 | |
Montelukast | Approved | Pharma | Antagonist | 302 | ||
ATP | Investigational | Nutra | Agonist, Activator, Partial agonist, Antagonist, Full agonist, Gating inhibitor, Pore Blocker, Potentiation, Target | 0 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs |
---|
ExUns: | 1a | · | 1b | ^ | 2 | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7a | · | 7b | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13 | ^ | 14 | ^ | 15 | ^ | 16 | ^ | 17 | ^ | 18 | ^ | 19 | ^ | 20 | ^ | 21 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | |||||||||||||||||||||||||||||||||||||||||||||
SP2: | - | ||||||||||||||||||||||||||||||||||||||||||||
SP3: | - |
This gene was present in the common ancestor of eukaryotes.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | ABCC9 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | ABCC9 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | ABCC9 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | ABCC9 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Abcc9 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Abcc9 30 |
|
||
Platypus (Ornithorhynchus anatinus) |
Mammalia | -- 31 |
|
ManyToMany | |
-- 31 |
|
ManyToMany | |||
-- 31 |
|
ManyToMany | |||
-- 31 |
|
ManyToMany | |||
Chicken (Gallus gallus) |
Aves | ABCC9 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | ABCC9 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | abcc9 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.18555 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | abcc9 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Sur 30 31 32 |
|
OneToMany | |
African malaria mosquito (Anopheles gambiae) |
Insecta | AgaP_AGAP009799 30 |
|
||
Worm (Caenorhabditis elegans) |
Secernentea | C18C4.2 32 |
|
|
|
Alicante grape (Vitis vinifera) |
eudicotyledons | Vvi.2081 30 |
|
||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
ManyToMany |
SNP ID | Clinical significance and condition | Chr 12 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
636608 | Uncertain Significance: not provided | 21,933,907(-) | GC/G | FRAMESHIFT_VARIANT | |
640130 | Uncertain Significance: Dilated cardiomyopathy 1O | 21,844,764(-) | T/G | INTRON_VARIANT | |
640543 | Uncertain Significance: Dilated cardiomyopathy 1O | 21,872,624(-) | C/T | SPLICE_DONOR_VARIANT | |
642464 | Uncertain Significance: Dilated cardiomyopathy 1O | 21,910,215(-) | G/A | MISSENSE_VARIANT | |
645509 | Uncertain Significance: Dilated cardiomyopathy 1O | 21,812,160(-) | G/A | INTRON_VARIANT |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv1937162 | CNV | deletion | 18987734 |
esv2109102 | CNV | deletion | 18987734 |
esv2142868 | CNV | deletion | 18987734 |
esv2439418 | CNV | insertion | 19546169 |
esv2662950 | CNV | deletion | 23128226 |
esv2745624 | CNV | deletion | 23290073 |
esv2745625 | CNV | deletion | 23290073 |
esv2745626 | CNV | deletion | 23290073 |
esv2745627 | CNV | deletion | 23290073 |
esv2745628 | CNV | deletion | 23290073 |
esv3580185 | CNV | loss | 25503493 |
nsv1122706 | CNV | deletion | 24896259 |
nsv470275 | CNV | gain | 18288195 |
nsv53503 | CNV | deletion | 16902084 |
nsv53790 | CNV | deletion | 16902084 |
nsv557741 | CNV | gain | 21841781 |
nsv557744 | CNV | loss | 21841781 |
nsv557754 | CNV | loss | 21841781 |
nsv557755 | CNV | loss | 21841781 |
nsv638 | CNV | insertion | 18451855 |
Disorder | Aliases | PubMed IDs |
---|---|---|
cantu syndrome |
|
|
cardiomyopathy, dilated, 1o |
|
|
atrial fibrillation, familial, 12 |
|
|
acromegaloid hypertrichosis syndrome |
|
|
acromegaloid facial appearance syndrome |
|
|